Ballantyne CM - Search Results

1

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.

Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J. Ballantyne CM, et al. Am Heart J. 2005 Mar;149(3):464-73. doi: 10.1016/j.ahj.2004.11.023. Am Heart J. 2005. PMID: 15864235 Clinical Trial.

2

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).

Ballantyne CM, Blazing MA, Hunninghake DB, Davidson MH, Yuan Z, DeLucca P, Ramsey KE, Hustad CM, Palmisano J. Ballantyne CM, et al. Am Heart J. 2003 Nov;146(5):862-9. doi: 10.1016/S0002-8703(03)00440-X. Am Heart J. 2003. PMID: 14597936 Clinical Trial.

3

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.

Ballantyne CM, Blazing MA, King TR, Brady WE, Palmisano J. Ballantyne CM, et al. Am J Cardiol. 2004 Jun 15;93(12):1487-94. doi: 10.1016/j.amjcard.2004.02.060. Am J Cardiol. 2004. PMID: 15194018 Clinical Trial.

4

LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.

McKenney J, Ballantyne CM, Feldman TA, Brady WE, Shah A, Davies MJ, Palmisano J, Mitchel YB. McKenney J, et al. Among authors: ballantyne cm. MedGenMed. 2005 Jul 14;7(3):3. MedGenMed. 2005. PMID: 16369229 Free PMC article. Clinical Trial.

5

Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.

Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM. Polis AB, et al. Among authors: ballantyne cm. Metab Syndr Relat Disord. 2009 Dec;7(6):601-10. doi: 10.1089/met.2009.0009. Metab Syndr Relat Disord. 2009. PMID: 19929597 Clinical Trial.

6

Role of lipid and lipoprotein profiles in risk assessment and therapy.

Ballantyne CM, Hoogeveen RC. Ballantyne CM, et al. Am Heart J. 2003 Aug;146(2):227-33. doi: 10.1016/S0002-8703(02)94701-0. Am Heart J. 2003. PMID: 12891189 Review.

7

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E; EXPLORER Study Investigators. Ballantyne CM, et al. Am J Cardiol. 2007 Mar 1;99(5):673-80. doi: 10.1016/j.amjcard.2006.10.022. Epub 2007 Jan 4. Am J Cardiol. 2007. PMID: 17317370 Clinical Trial.

8

Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).

Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH. Ballantyne CM, et al. Am J Cardiol. 2008 May 15;101(10):1428-36. doi: 10.1016/j.amjcard.2008.02.092. Am J Cardiol. 2008. PMID: 18471454 Clinical Trial.

9

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses.

Abate N, Catapano AL, Ballantyne CM, Davidson MH, Polis A, Smugar SS, Tershakovec AM. Abate N, et al. Among authors: ballantyne cm. J Clin Lipidol. 2008 Apr;2(2):91-105. doi: 10.1016/j.jacl.2008.02.002. Epub 2008 Feb 15. J Clin Lipidol. 2008. PMID: 21291725

10

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein.

Davidson MH, Abate N, Ballantyne CM, Catapano AL, Xu X, Lin J, Rosenberg E, Tershakovec AM. Davidson MH, et al. Among authors: ballantyne cm. J Clin Lipidol. 2008 Dec;2(6):436-46. doi: 10.1016/j.jacl.2008.10.003. Epub 2008 Oct 22. J Clin Lipidol. 2008. PMID: 21291777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters